Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer

Table 1

Patient characteristic and pathological features.

Features	No. (%)
Gender
Female	9/32 (28.1)
Male	23/32 (71.9)
Age (years)
<60	21/32 (65.7)
60–70	6/32 (18.7)
>70	5/32 (15.6)
Tumor size (cm)
<3	6/32 (18.7)
>3	26/32 (81.3)
Tumor stage
I	16/32 (50.0)
II	7/32 (21.9)
III A	2/32 (6.3)
III B	1/32 (3.1)
IV	6/32 (18.7)
Histopathological type
Squamous cell carcinoma	12/32 (37.5)
Adenocarcinoma	9/32 (28.1)
Large cell carcinoma	9/32 (28.1)
Other	2/32 (6.3)
Grade of differentiation
Well	3/32 (9.4)
Moderate	13/32 (40.6)
Poor	14/32 (43.7)
Undifferentiated	2/32 (6.3)
Degree of cell pleomorphism
No evident	3/32 (9.4)
Low	10/32 (31.2)
Moderate	11/32 (34.4)
High	8/32 (25.0)
Necrosis index
No evident	9/32 (28.1)
<50%	12/32 (37.5)
>50%	11/32 (34.4)
Mitotic index
No evident	2/32 (6.3)
Low	10/32 (31.2)
Moderate	15/32 (46.9)
High	5/32 (15.6)

No. Number of cases, % percentages.